You are here

  • Home
  • Archive
  • Volume 58, Issue 12
  • Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFα reduce colitis-associated colorectal carcinogenesis?

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFα reduce colitis-associated colorectal carcinogenesis?

https://doi.org/10.1136/gut.2008.176461

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding “Fondazione Umberto Di Mario”, Largo Marchiafava 1, Rome.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.